Catalog No.
VVV21101
Species reactivity
Varicella-zoster virus (strain Oka vaccine) (HHV-3) (Human herpesvirus 3)
Host species
Human
Isotype
IgG1, kappa
Clonality
Monoclonal
Target
Envelope glycoprotein H, gH, gH, ORF37, Envelope glycoprotein L, gL, gL, ORF60, gH/gL Complexes
Concentration
1.49 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q775J3 & Q9J3N1
Applications
ELISA, Neutralization
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
Iv0041
Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse Model., PMID:39066412
Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis., PMID:37519635
Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study., PMID:37046283
Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents., PMID:36967248
Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections., PMID:36572250
The N-terminus of varicella-zoster virus glycoprotein B has a functional role in fusion., PMID:33411789
Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis., PMID:33259590
The landscape of host genetic factors involved in immune response to common viral infections., PMID:33109261
Acyclovir-induced immune thrombocytopenia: Case report and review of the literature., PMID:32905113
The presence of herpes simplex-1 and varicella zoster viruses is not related with clinical outcome of Bell's Palsy., PMID:32858308
Evaluation of immunogenicity, safety and breakthrough following administration of live attenuated varicella vaccine in two doses three months apart regimen in Indian children., PMID:32851202
A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation., PMID:32811830
The landscape of host genetic factors involved in immune response to common viral infections., PMID:32511533
Complex interaction between mutant HNRNPA1 and gE of varicella zoster virus in pathogenesis of multiple sclerosis., PMID:29996671
Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients., PMID:29118328
Varicella-zoster virus ORF7 interacts with ORF53 and plays a role in its trans-Golgi network localization., PMID:29116592
Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections., PMID:28238255
Role for the αV Integrin Subunit in Varicella-Zoster Virus-Mediated Fusion and Infection., PMID:27279620
Anti-cytokine autoantibodies in postherpetic neuralgia., PMID:26482341
A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL., PMID:25918416
The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging., PMID:25734814
Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection., PMID:23077312
Are human herpes viruses associated with autoimmune thyroid disease?, PMID:22169789
Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex., PMID:21988664
Development and evaluation of an immunochromatographic strip for the detection of Human cytomegalovirus., PMID:21244452
Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins., PMID:19720242
Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner., PMID:18562514
Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway., PMID:17113160
The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator., PMID:17079304
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses., PMID:15782388
Idiopathic CD4+ lymphocytopenia and juvenile laryngeal papillomatosis., PMID:15668935
Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope., PMID:15613328
Cellular and humoral immune abnormalities in Gulf War veterans., PMID:15175170
Does a viral infection cause complex regional pain syndrome?, PMID:14998056
Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine., PMID:14604566
Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus., PMID:12820183
Varicella-zoster virus productively infects mature dendritic cells and alters their immune function., PMID:12663800
Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia., PMID:12562395
[T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient]., PMID:11530503
Screening of patients with complex regional pain syndrome for antecedent infections., PMID:11444711
Optic neuritis in herpes zoster ophthalmicus., PMID:11033135
Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain., PMID:10864674
Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination., PMID:10651069
Isolation and initial characterization of the BRCA2 promoter., PMID:10557089
Early and late onset manifestations of cerebral vasculitis related to varicella zoster., PMID:9762696
Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine., PMID:9682389
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking., PMID:9343180
Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein., PMID:8757993
Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene., PMID:8627224
Humoral immunity in DiGeorge syndrome., PMID:7636647
For research use only. Not for human or drug use.
